About ISMP Canada

The Institute for Safe Medication Practices Canada is a national, independent, and not-for-profit organization that purposefully partners with organizations, practitioners, consumers, and caregivers to advance medication safety in all healthcare settings.

The Next Five Years – Strategic Plan 2022 to 2026

Learn, Share, Act

Download PDF

About

The Institute for Safe Medication Practices Canada is a national, independent, and not-for-profit organization that purposefully partners with organizations, practitioners, consumers, and caregivers to advance medication safety in all healthcare settings.

Our Vision:  Zero preventable harm from medications.

Our Values: 

  • Quality, Reliability, and Integrity: A quality, high integrity, reliable system for reporting medication incidents.
  • Learning, Sharing, and Empowering: Knowledge translation about medication system safeguards.
  • Privacy and Confidentiality: Maintaining and protecting the confidentiality of individuals and organizations submitting data to ISMP Canada.
  • Research and Innovation: Advancing research and innovation in the area of patient safety.
  • Trust and Transparency: Ensuring our actions are conducted with honesty and transparency, and funding is free of conflict of interest and consistent with our not-for-profit, independent status.

Board of Directors

The Directors on the Board are a diverse group of leaders from across Canada with a passion for medication safety. They govern ISMP Canada by approving the organization’s vision, mission, and strategic directions then ensuring they are accomplished. The Directors adhere to conflict of interest and other related policies.

Board of Directors

Leadership Team

Careers

ISMP Canada offers exciting career opportunities. Our current positions are listed below. Qualified applicants are encouraged to forward their résumé to HR@ismpcanada.ca or, you can submit your résumé for future consideration at any time.

 

Current Opportunities

Privacy

What information does ISMP Canada receive?

All information received by ISMP Canada is provided voluntarily by individual healthcare practitioners, consumers and institutions. ISMP Canada receives two types of information:

  • Non-identifiable information about a medication incident, such as: description of the incident, patient outcome, type of healthcare facility where the incident occurred, the names and dosages of the medications involved, description of how the incident was discovered, contributing factors and recommendations to prevent similar incidents in the future.
  • Additional information about a medication incident, such as: information about the patient’s medical condition, the types of healthcare practitioners involved in the incident, and the reporter’s contact information may be provided voluntarily to ISMP Canada. In some cases, ISMP Canada may be invited to work jointly with reporting healthcare practitioners and institutions to investigate a specific incident (called a “root cause analysis”) and provide recommendations for avoiding similar incidents in the future.

How does ISMP Canada obtain information?

ISMP Canada receives information on medication incidents from individual healthcare practitioners, consumers and institutions, via telephone, email, mail, fax, or web-based reporting programs. In addition, hospitals may report anonymous information on medication incidents through ISMP Canada’s “Analyze-ERR”, a software documentation tool designed by ISMP Canada to track and analyze medication errors.

Does ISMP Canada collect identifiable data on patients?

Please remember that ISMP Canada does not need to collect information that directly identifies a patient. ISMP Canada requests that all identifying information about patients be removed prior to any report being shared with ISMP Canada. Individual healthcare practitioners and consumers may choose to provide their contact information for the purpose of allowing ISMP Canada to carry out follow-up investigations or to clarify information relating to a specific medication incident, but ISMP Canada never needs to know the names of individual patients involved in medication incidents.

 

Privacy Policy

Privacy Policy FAQs

Privacy Policy Brochure

ISMP Canada’s Guidance for Sharing Medication Incident Data in the Era of Ontario’s PHIPA, QCIPA and FIPPA

Privacy Impact Assessment (PIA) on Analyze-ERR® and Current Data Handling Operations